CRISPRQC INC. — Form D
CRISPRQC INC. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-22. The offering totals $4.0M, of which $885K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-03-22
- Form: D
- Accession: 0001916528-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $885K
- Remaining: $3.1M
- Investors: 7
- Date of first sale: 2022-03-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438283
Issuer
- Name: CRISPRQC INC.
- CIK: 0001916528
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 8949 KENAMAR DR, SAN DIEGO, CA, 92121
- Phone: (858) 444-0037
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Michael Heltzen | Director | San Diego, CA |
| Ross Helgren Bundy | Executive Officer | San Diego, CA |
| Ross Bundy | Director | San Diego, CA |
| Ross Bundy | Executive Officer | San Diego, CA |
| George Bonaros | Director | San Diego, CA |
| Paul Grint | Director | San Diego, CA |
| Kiana Aran | Director | San Diego, CA |
| Toby Richardson | Director | San Diego, CA |
| Chris Yoo | Director | San Diego, CA |
Other filings by this issuer (3)
More